Roger Song

Stock Analyst at Jefferies

(0.49)
# 2685
Out of 5,441 analysts
54
Total ratings
Success rate
Average return
34 Stocks
Name Action PT Current % Upside Ratings Updated
MBX MBX Biosciences
Assumes: Buy
36
11.2 221.43% 1 Aug 15, 2025
LVTX LAVA Therapeutics
Downgrades: Hold
3 2
1.52 -1.32% 1 Aug 5, 2025
KNSA Kiniksa Pharmaceutic...
Maintains: Strong Buy
45 54
32.74 64.94% 3 Jul 29, 2025
REPL Replimune Group
Maintains: Buy
31 6
4.98 20.48% 2 Jul 22, 2025
VERV Verve Therapeutics
Downgrades: Hold
28 11
11.13 -1.17% 1 Jun 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
7 5
5.42 -7.75% 1 Jun 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
15 30
22.48 33.45% 8 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
3.35 79.1% 1 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
7
2.9 141.38% 1 Mar 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
245
137.58 78.08% 1 Mar 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
26
8.11 220.59% 1 Feb 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
48 2
1.28 56.25% 2 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
42 7
4.34 61.29% 2 Dec 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 28
5.54 405.42% 2 Nov 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
2 7
1.64 326.83% 1 Nov 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
89
58.61 51.85% 1 Oct 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
31 25
8.04 210.95% 2 Oct 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
41
9.64 325.31% 1 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
35
14.97 133.8% 1 Oct 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
5.61 60.43% 1 Sep 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
108 129
29.7 334.34% 1 Sep 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
3 8
2.31 246.32% 3 May 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
97
74.98 29.37% 1 Apr 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
41 72
21.06 241.88% 2 Mar 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
110
38.19 188.03% 1 Mar 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
31 2
2.65 -24.53% 2 Sep 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
30 35
3.38 935.5% 1 Aug 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
0.82 997.56% 1 Jul 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
675
2.05 32826.83% 1 Jan 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
8
4.37 83.07% 2 Dec 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
300 400
15.71 2446.15% 2 Nov 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
30
n/a n/a 1 Feb 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
315
n/a n/a 1 Sep 8, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
21
0.77 2627.27% 1 Sep 2, 2020